JP2004534810A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534810A5
JP2004534810A5 JP2003506872A JP2003506872A JP2004534810A5 JP 2004534810 A5 JP2004534810 A5 JP 2004534810A5 JP 2003506872 A JP2003506872 A JP 2003506872A JP 2003506872 A JP2003506872 A JP 2003506872A JP 2004534810 A5 JP2004534810 A5 JP 2004534810A5
Authority
JP
Japan
Prior art keywords
days
practically
suspended
appropriate
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003506872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534810A (ja
JP4880871B2 (ja
Filing date
Publication date
Priority claimed from FR0108157A external-priority patent/FR2826274B1/fr
Application filed filed Critical
Publication of JP2004534810A publication Critical patent/JP2004534810A/ja
Publication of JP2004534810A5 publication Critical patent/JP2004534810A5/ja
Application granted granted Critical
Publication of JP4880871B2 publication Critical patent/JP4880871B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003506872A 2001-06-21 2002-06-21 味覚を遮蔽した医薬処方物およびその製造方法 Expired - Fee Related JP4880871B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/08157 2001-06-21
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (3)

Publication Number Publication Date
JP2004534810A JP2004534810A (ja) 2004-11-18
JP2004534810A5 true JP2004534810A5 (enExample) 2008-12-11
JP4880871B2 JP4880871B2 (ja) 2012-02-22

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506872A Expired - Fee Related JP4880871B2 (ja) 2001-06-21 2002-06-21 味覚を遮蔽した医薬処方物およびその製造方法

Country Status (41)

Country Link
US (2) US7138138B2 (enExample)
EP (1) EP1401397B1 (enExample)
JP (1) JP4880871B2 (enExample)
CN (1) CN1239149C (enExample)
AP (1) AP1595A (enExample)
AR (1) AR036096A1 (enExample)
AT (1) ATE290366T1 (enExample)
AU (1) AU2002329311B2 (enExample)
BG (1) BG66314B1 (enExample)
BR (1) BRPI0208998A2 (enExample)
CA (1) CA2452239C (enExample)
CO (1) CO5540278A2 (enExample)
CZ (1) CZ299947B6 (enExample)
DE (1) DE60203178T2 (enExample)
EA (1) EA006016B1 (enExample)
EC (1) ECSP034915A (enExample)
ES (1) ES2236574T3 (enExample)
FR (1) FR2826274B1 (enExample)
GT (2) GT200200115A (enExample)
HR (1) HRP20031067B1 (enExample)
HU (1) HUP0400799A3 (enExample)
IL (2) IL159404A0 (enExample)
JO (1) JO2325B1 (enExample)
MA (1) MA27042A1 (enExample)
MX (1) MXPA03011756A (enExample)
MY (1) MY134340A (enExample)
NO (1) NO332258B1 (enExample)
NZ (1) NZ530042A (enExample)
OA (1) OA12635A (enExample)
PA (1) PA8548301A1 (enExample)
PE (1) PE20030201A1 (enExample)
PL (1) PL202090B1 (enExample)
PT (1) PT1401397E (enExample)
SK (1) SK285865B6 (enExample)
SV (1) SV2003001098A (enExample)
TN (1) TNSN03141A1 (enExample)
TW (1) TWI228049B (enExample)
UA (1) UA77960C2 (enExample)
UY (1) UY27341A1 (enExample)
WO (1) WO2003000225A2 (enExample)
ZA (1) ZA200309479B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
SI1978936T1 (sl) * 2006-02-03 2013-10-30 Evonik Roehm Gmbh Farmacevtski sestavki, ki vsebujejo mešanice polimerov in v vodi slabo topna aktivna sredstva
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
NZ593559A (en) 2008-12-16 2013-05-31 Carlsberg As Coating of hydroxylated surfaces by gas phase grafting
IN2014DN08939A (enExample) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
CA2957034A1 (en) * 2014-08-05 2016-02-11 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
EP1027036A2 (en) * 1997-10-03 2000-08-16 ELAN CORPORATION, Plc Taste masked formulations
IN191239B (enExample) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
KR100502031B1 (ko) * 2000-08-22 2005-07-25 바실리어 파마슈티카 아게 항균 활성을 갖는 신규한 매크롤라이드

Similar Documents

Publication Publication Date Title
JP2004534810A5 (enExample)
NO2017051I2 (no) Kariprazin, eventuelt i form av et salt
JP2006213929A5 (enExample)
JP2003286379A5 (enExample)
JP2004514660A (ja) Hsp90に結合するための小分子組成物
JP2002533216A5 (enExample)
JP2006517944A5 (enExample)
JP2005515295A5 (enExample)
DE602005027899D1 (de) Mundpflegezusammensetzung mit dem extrakt von unoxidierter kamelie
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
JP2006511228A5 (enExample)
JP2005501564A5 (enExample)
NL1025710A1 (nl) Azabicyclische pyridyloxymethyl- en benzisoxazoolderivaten.
JP2005501968A5 (enExample)
JP2008534513A5 (enExample)
JP2004529205A5 (enExample)
FI20041641L (fi) Sovitelma silmänpainemittarissa
DE602005010079D1 (de) Undheit, der immunität und des wachstums bei schalentieren
JP2003284553A5 (enExample)
JP2007513894A5 (ja) Chp−ゲムシタビン複合剤および抗腫瘍剤、特に抗転移剤としてのその使用
JP2006501334A5 (enExample)
JP2007508806A5 (enExample)
DK1758609T3 (da) Vaccine mod HPV 16 og HPV 18 og mindst en anden HPV-type udvalgt blandt HPV 31, 45 eller 52
RU2003120857A (ru) Адаптогенное средство
Smyth The Niitsitapi trade: Euroamericans and the Blackfoot-Speaking Peoples, to the mid-1830s